BXP, Inc. (BXP)
(Delayed Data from NYSE)
$79.68 USD
-0.78 (-0.97%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $79.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$79.68 USD
-0.78 (-0.97%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $79.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
BXP Stock Rallies 30.4% in 3 Months: Will it Continue to Rise?
by Zacks Equity Research
BXP is set to gain from a rise in demand for top-quality office spaces driven by technology, life science business and its prudent capital-management practices.
BXP Rallies 19.5% in 3 Months: Will It Continue to Rise?
by Zacks Equity Research
BXP's assets in a few select markets, diversified tenant base, strategic expansions and a solid balance sheet position bode well for future growth.
Ventas (VTR) Q2 FFO Beats Estimates on Higher Same-Store NOI
by Zacks Equity Research
Ventas' (VTR) Q2 results reflect occupancy and revenue growth in its same-store senior housing operating portfolio.
Do Options Traders Know Something About BXP Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to BXP stock based on the movements in the options market lately.
BXP's Q2 FFO Outpaces Estimates, Lease Revenues Rise Y/Y
by Zacks Equity Research
BXP's Q2 results beat estimates on better-than-anticipated revenues, aided by healthy leasing activity. It has raised the 2024 FFO per share guidance.
Compared to Estimates, Boston Properties (BXP) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Boston Properties (BXP) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Boston Properties (BXP) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Boston Properties (BXP) delivered FFO and revenue surprises of 2.91% and 1.18%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Iron Mountain (IRM) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Iron Mountain's (IRM) Q2 results are likely to be aided by strength in core storage and record management businesses and solid data center demand. However, high interest expenses remain a concern.
BXP Gears Up to Report Q2 Earnings: Key Factors to Consider
by Zacks Equity Research
BXP's Q2 earnings are likely to have benefited from healthy demand for premium office and life-science assets. However, high interest rates remain a concern.
Is it Wise to Retain Boston Properties (BXP) Stock for Now?
by Zacks Equity Research
Healthy demand for premier office spaces and long-term leases from tenants bode well for Boston Properties (BXP). However, elevated interest rates continue to be a concern.
Ventas (VTR) Q1 FFO Beats Estimates on Higher Same-Store NOI
by Zacks Equity Research
Ventas' (VTR) Q1 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves year over year on strong performance.
Boston Properties (BXP) Q1 FFO Meet Estimates, '24 View Lowered
by Zacks Equity Research
Boston Properties' (BXP) Q1 results meet estimates on better-than-anticipated revenues, aided by healthy leasing activity. It lowers the 2024 FFO per share guidance.
Here's What Key Metrics Tell Us About Boston Properties (BXP) Q1 Earnings
by Zacks Equity Research
The headline numbers for Boston Properties (BXP) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Boston Properties (BXP) Q1 FFO Meet Estimates
by Zacks Equity Research
Boston Properties (BXP) delivered FFO and revenue surprises of 0% and 2.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Host Hotels (HST) in Q1 Earnings?
by Zacks Equity Research
Host Hotels' (HST) Q1 earnings are likely to have benefited from the continued recovery in group travel and business transient demand. However, high interest expenses raise concerns.
Iron Mountain (IRM) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Strength in core storage and record management businesses and solid data center demand are likely to have aided Iron Mountain's (IRM) Q1 earnings. However, high interest expenses remain a concern.
Should You Buy Boston Properties (BXP) Ahead of Earnings?
by Zacks Equity Research
Boston Properties (BXP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Key Factors to Impact Boston Properties' (BXP) Q1 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q1 earnings. However, high interest expenses remain a concern.
Alexandria (ARE) Beats Q1 AFFO Estimates, Narrows '24 Guidance
by Zacks Equity Research
Alexandria's (ARE) Q1 results reflect healthy leasing activity and rental rate growth.
Stock Market News for Apr 11, 2024
by Zacks Equity Research
Wall Street closed sharply lower on Wednesday, in a broad-based slump.
Boston Properties (BXP) Closes Stake Sale in Kendall Square Asset
by Zacks Equity Research
Boston Properties' (BXP) latest stake sale helps it capitalize on the value that investors are placing on well-positioned, well-managed and well-leased premier workplaces.
Is it Wise to Retain Boston Properties (BXP) Stock for Now?
by Zacks Equity Research
Healthy demand for premier office spaces and life-science portfolio expansion bode well for Boston Properties (BXP). Overall office real estate market choppiness and high interest rates are woes.
Ventas' (VTR) Q4 FFO Meets Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves across the portfolio. It has also issued its 2024 outlook.
Welltower (WELL) Q4 FFO Beat Estimates, SHO Occupancy Rises
by Zacks Equity Research
Welltower's (WELL) Q4 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year.
Healthpeak's (PEAK) Q4 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (PEAK) Q4 results outshine estimates on better-than-anticipated revenues. Same-store cash NOI for the total portfolio improves year over year. It has issued its 2024 outlook.